Success Stories: With Our Meticulous Efforts, A Chinese Assistant Scientist Secured his EB1-A Approval in the Field of Molecular Biology in just 6 days, Premium Processing Requested

On September 6th, 2023, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Scientist in the Field of Molecular Biology (Approval Notice).


General Field: Molecular Biology

Position at the Time of Case Filing: Assistant Scientist

Country of Origin: China

State of Residence at the Time of Filing: Georgia

Approval Notice Date: September 6th, 2023

Processing Time: 6 days (Premium Processing Requested)


Case Summary:

An Assistant Scientist approached the North America Immigration Law Group to file his alien of extraordinary ability (EB1-A) petition. Hailing from China, he has completed his Ph.D. in biochemistry and molecular biology and is also currently employed in the same field.

Since, a petition for the first preference category of individuals with extraordinary ability, (“EB1-A”), unlike the employment-based immigration visa under the second preference (“EB-2”) at least requires the following:

  1. Evidence of original contributions, usually through publication, of major significance in the foreign national’s field of science, scholastic, artistic, or athletic.
  2. No specific job offer/labor certification is required for a foreign person as long as he/she is entering the United States to continue work in the field in which he/she has an extraordinary ability, therefore self-petition is allowed.
  3. Performance in a significant role for organizations or establishments that have a distinguished reputation.
  4. Receipt of a higher salary or remuneration than is usual in the field.
  5. Other comparable evidence if the above types of evidence do not readily apply to the foreign national’s occupation.
Therefore, we included the following essentials from his academic and professional records in his petition packet to make a convincing case in his favor:
  • His research on RNA editing and functionality and gene expression and regulation in health and disease addresses some of our nation’s and the world’s most pressing issues, including improving our understanding of the genetic and molecular mechanisms underlying diseases that pose a major global public health burden like cancers to facilitate the discovery and development of novel therapeutic and diagnostic approaches for these diseases.
  • His research has resulted in 12 peer-reviewed scientific articles, being cited 3,645 times in thousands of countries.
  • He has conducted at least 43 reviews to date.
Our client’s work has thus been majorly significant, and his achievements are of the utmost importance due to their direct applicability in global efforts to address gaps in the literature on RNA biology and provide novel insights into the molecular mechanisms underlying diseases such as cancer.
  • Four fellow experts in the field further provided insight into the significance of his continuing research in the field.
Finally, he achieved his EB1-A (Alien of Extraordinary Ability) approval in just 6 days (thanks to premium processing). We are happy to have been a part of his successful journey and wish him a flourishing life ahead.